Skip to content

COVAIL COVID-19 Vaccine Trial

The purpose of this clinical trial is to test the safety and effectiveness of additional COVID-19 booster doses in people who have already received a primary COVID-19 vaccination series and booster dose. Participants will have completed a primary COVID-19 vaccination series (2 doses of Pfizer, 2 doses of Moderna, or 1 dose of Johnson & Johnson) and received a booster at least 16 weeks prior to joining the study.

Immunity Study

We have identified a genetic marker in people of African descent that could increase the risk of acquiring HIV. The purpose of this study is to find out whether factors in the genital area of the body can change how your body fights HIV.

Skip to toolbar